NeuroSense Therapeutics Ltd. (NRSN)

NASDAQ: NRSN · Real-Time Price · USD

1.900

0.00 (0.00%)

At close: Jul 2, 2025, 4:00 PM

1.940

+0.040 (2.11%)

After-hours: Jul 2, 2025, 6:11 PM EDT

NeuroSense Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for NeuroSense Therapeutics stock have an average target of 14, which predicts a 636.84% increase from the current stock price of 1.9.

Price Target: $14 (+636.84%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$14	$14	$14
Change	+636.84%	+636.84%	+636.84%	+636.84%

* Price targets were last updated on May 12, 2025.

Analyst Ratings

The average analyst rating for NeuroSense Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	0	0	0	1	1
Buy	0	0	0	0	0
Hold	1	1	1	1	1
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Initiates $14	Strong Buy	Initiates	$14	+636.84%	May 12, 2025
Naz Rahman Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Dec 16, 2024
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $7.5	Strong Buy	Initiates	$7.5	+294.74%	Jul 17, 2023
Naz Rahman Maxim Group	Maxim Group	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+268.42%	Jan 7, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 189.65M

Revenue Next Year

n/a

EPS This Year

-0.61

from -0.55

EPS Next Year

-0.36

from -0.61

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	1.09M	6.69M	6.82M	189.65M
Revenue Growth	-	-	512.36%	2.00%	2,680.38%	-	-	-
EPS	-0.51	-0.52	-0.91	-0.74	-0.55	-0.61	-0.36	-0.20
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	2.2M	6.9M
Avg	n/a	1.1M	6.7M
Low	n/a	n/a	6.4M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	530.4%
Avg	-	-	512.4%
Low	-	-	488.4%

EPS Forecast

EPS	2025	2026	2027
High	-0.62	-0.16	-0.21
Avg	-0.61	-0.36	-0.20
Low	-0.59	-0.54	-0.20

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.